These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 26501825)
21. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy. Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957 [TBL] [Abstract][Full Text] [Related]
22. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563 [TBL] [Abstract][Full Text] [Related]
23. Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios. Kupitz D; Wetz C; Wissel H; Wedel F; Apostolova I; Wallbaum T; Ricke J; Amthauer H; Grosser OS PLoS One; 2017; 12(11):e0187570. PubMed ID: 29107992 [TBL] [Abstract][Full Text] [Related]
24. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093 [No Abstract] [Full Text] [Related]
25. The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC. Schuchardt C; Kulkarni HR; Prasad V; Zachert C; Müller D; Baum RP Recent Results Cancer Res; 2013; 194():519-36. PubMed ID: 22918780 [TBL] [Abstract][Full Text] [Related]
26. Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution. Hippeläinen ET; Tenhunen MJ; Mäenpää HO; Heikkonen JJ; Sohlberg AO Nucl Med Commun; 2017 May; 38(5):357-365. PubMed ID: 28338529 [TBL] [Abstract][Full Text] [Related]
27. Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment. Sandström M; Garske-Román U; Granberg D; Johansson S; Widström C; Eriksson B; Sundin A; Lundqvist H; Lubberink M J Nucl Med; 2013 Jan; 54(1):33-41. PubMed ID: 23223392 [TBL] [Abstract][Full Text] [Related]
28. A novel planar image-based method for bone marrow dosimetry in (177)Lu-DOTATATE treatment correlates with haematological toxicity. Svensson J; Rydén T; Hagmarker L; Hemmingsson J; Wängberg B; Bernhardt P EJNMMI Phys; 2016 Dec; 3(1):21. PubMed ID: 27654452 [TBL] [Abstract][Full Text] [Related]
29. A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [ Pirozzi Palmese V; D'Ambrosio L; Di Gennaro F; Maisto C; de Marino R; Morisco A; Coluccia S; Di Gennaro P; De Lauro F; Raddi M; Gaballo P; Tafuto S; Celentano E; Lastoria S Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1753-1764. PubMed ID: 36688980 [TBL] [Abstract][Full Text] [Related]
30. A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours. Forrer F; Uusijärvi H; Waldherr C; Cremonesi M; Bernhardt P; Mueller-Brand J; Maecke HR Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1257-62. PubMed ID: 15197500 [TBL] [Abstract][Full Text] [Related]
31. Comparison of commercial dosimetric software platforms in patients treated with Mora-Ramirez E; Santoro L; Cassol E; Ocampo-Ramos JC; Clayton N; Kayal G; Chouaf S; Trauchessec D; Pouget JP; Kotzki PO; Deshayes E; Bardiès M Med Phys; 2020 Sep; 47(9):4602-4615. PubMed ID: 32632928 [TBL] [Abstract][Full Text] [Related]
32. Clinical implementation of PLANET® Dose for dosimetric assessment after [ Santoro L; Pitalot L; Trauchessec D; Mora-Ramirez E; Kotzki PO; Bardiès M; Deshayes E EJNMMI Res; 2021 Jan; 11(1):1. PubMed ID: 33394212 [TBL] [Abstract][Full Text] [Related]
34. Effect of image registration on 3D absorbed dose calculations in Grassi E; Fioroni F; Berenato S; Patterson N; Ferri V; Braglia L; Filice A; Versari A; Iori M; Spezi E Phys Med; 2018 Jan; 45():177-185. PubMed ID: 29472084 [TBL] [Abstract][Full Text] [Related]
35. Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses. Makris NE; van Velden FH; Huisman MC; Menke CW; Lammertsma AA; Boellaard R Med Phys; 2014 Oct; 41(10):102503. PubMed ID: 25281978 [TBL] [Abstract][Full Text] [Related]
36. Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT). Chicheportiche A; Artoul F; Schwartz A; Grozinsky-Glasberg S; Meirovitz A; Gross DJ; Godefroy J EJNMMI Phys; 2018 Jun; 5(1):10. PubMed ID: 29916115 [TBL] [Abstract][Full Text] [Related]
37. Technical note: Impact of dose voxel kernel (DVK) values on dosimetry estimates in Danieli R; Pistone D; Tranel J; Botta F; Uribe-Munoz C; Raspanti D; Salvat F; Wilderman SJ; Bardiès M; Amato E; Dewaraja YK; Cremonesi M Med Phys; 2024 Jan; 51(1):522-532. PubMed ID: 37712869 [TBL] [Abstract][Full Text] [Related]
38. Fast voxel-level dosimetry for (177)Lu labelled peptide treatments. Hippeläinen E; Tenhunen M; Sohlberg A Phys Med Biol; 2015 Sep; 60(17):6685-700. PubMed ID: 26270032 [TBL] [Abstract][Full Text] [Related]
39. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for Peterson AB; Mirando DM; Dewaraja YK EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783 [TBL] [Abstract][Full Text] [Related]
40. A Comparison of 2D and 3D Kidney Absorbed Dose Measures in Patients Receiving Willowson KP; Ryu H; Jackson P; Singh A; Eslick E; Bailey DL Asia Ocean J Nucl Med Biol; 2018; 6(2):113-119. PubMed ID: 29998144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]